Cargando…
LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia
Autores principales: | Ruggero, K, Al-Assar, O, Chambers, J S, Codrington, R, Brend, T, Rabbitts, T H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5227057/ https://www.ncbi.nlm.nih.gov/pubmed/27256700 http://dx.doi.org/10.1038/leu.2016.116 |
Ejemplares similares
-
LMO2 at 25 years: a paradigm of chromosomal translocation proteins
por: Chambers, Jennifer, et al.
Publicado: (2015) -
Comparison of biological features between severely immuno-deficient
NOD/Shi-scid Il2rg(null) and NOD/LtSz-scid
Il2rg(null) mice
por: Nagatani, Mariko, et al.
Publicado: (2019) -
Competitive SPR using an intracellular anti-LMO2 antibody identifies novel LMO2-interacting compounds
por: Canning, Peter, et al.
Publicado: (2021) -
Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition
por: Abdulla, Hesham D., et al.
Publicado: (2023) -
Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model
por: Pais, Helio, et al.
Publicado: (2019)